承诺项目:试点研究,通过药剂师领导的精神药物管理计划改善老年护理
Marie d'Amours1,2, Farah Ettis1,2, Lauriane Ginefri1,2
1Pharmacy Department, Jewish General Hospital, 3755 Chemin de la Côte-Ste-Catherine, Montréal, QC, H3T 1E2, Canada.
Drugs & aging
|September 27, 2023
概括
在老年人急性护理中,药剂师领导的精神药物管理计划是可行的. 这项试点研究表明,抑郁症的接受率和接受率很高,改善了老年人护理.
科学领域:
- 老年医学 老年医学
- 药理学 药理学是指药理学的学科.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 精神药物通常在急性护理中被处方,对老年人来说存在风险.
- 长期不适当使用这些药物会增加老年人患病率和死亡率.
- 需要制定战略,以优化老年人群中心理药物使用.
研究的目的:
- 评估药剂师领导的精神药物药物管理计划的可行性.
- 评估在外科病房的老年患者中减轻精神药物的处方潜力.
- 确定药剂师建议对药物管理的影响.
主要方法:
- 展望性,观察性试点研究,涉及75岁及以上的患者.
- 评估精神药物 (抗精神病药物,二胺,非二胺受体激动剂) 对于抑郁症的适用性.
- 药剂师主导的干预,向医疗团队提出建议.
主要成果:
- 93.4%的患者有资格获得潜在的抑郁症.
- 药剂师评估了298个处方,其中69.8%的处方被推为抑郁症.
- 75.4%的抑郁症建议被接受,84.8%的抑郁症建议在出院后继续存在.
结论:
- 在急性外科护理环境中,药剂师领导的精神药物管理计划是可行的.
- 这项计划有望提高老年护理的质量.
- 药剂师的干预可以有效地减少老年患者不适当的精神药物使用.
更多相关视频
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.1K
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
12.9K
相关概念视频
Drug Therapy
60
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
60
Psychosis: Goals of Pharmacotherapy
158
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
158
Acute Coronary Syndrome IV: Interprofessional Care
11
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
Restorative Care
2.0K
Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
2.0K
Community Based Intervention
57
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
57
Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
